BackGeneReach Biotechnology Overview

GeneReach Biotechnology Inventory

Track GeneReach Biotechnology's inventory ($44M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$43.95M
↑ 21.84% YoYΔ $7.88M vs prior year quarter

Peer trimmed avg / median

Loading

GeneReach Biotechnology Inventory History

Loading

GeneReach Biotechnology vs. peers: Inventory Comparison

Loading

GeneReach Biotechnology Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GeneReach Biotechnology (4171.TWO) FAQ

As of the most recent data (September 2026), 4171.TWO shows a inventory of $44M. That compares with $36M in the prior-year period — up 21.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4171.TWO's inventory is now $44M (was $36M) — a 21.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether GeneReach Biotechnology is outperforming or lagging.

Tracking 4171.TWO's inventory over time shows whether GeneReach Biotechnology is scaling, shrinking, or reshaping that part of the business. The current reading is $44M That compares with $36M in the prior-year period — up 21.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has GeneReach Biotechnology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $44M) with ownership activity and broader fundamentals.

GeneReach Biotechnology's inventory is $44M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.

Questions & Answers